• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ:IMRN)

1.030 -0.170 (-14.17%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Immuron Limited - American Depositary Shares

< Previous 1 2 3 Next >
News headline image
Immuron New U.S. Department of Defense Award & Clinical Trial Update
December 03, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron IMM-529 IND approved by FDA
November 05, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces Clinical Trial Update
October 31, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target
October 17, 2025
New York, New York--(Newsfile Corp. - October 17, 2025) - Emerging Growth Research today announced the initiation of coverage on... 
Via Newsfile
News headline image
Immuron Q1 FY26 YoY growth
October 13, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Submits IMM-529 IND to FDA
October 08, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Letter to Shareholders – Projects Update
October 02, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron partners with InvestorHub
August 26, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron - FY25 global sales exceed projection, up 49% on prior year
July 17, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Letter to Shareholders: Projects Update
May 30, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Travelan® highest sales in history
April 10, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
March 05, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Travelan® continued strong sales growth
January 17, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
January 15, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces Travelan® Clinical Trial Update
January 14, 2025
From Immuron Limited
Via GlobeNewswire
News headline image
UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
December 06, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
December 06, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
December 03, 2024
Via ACCESSWIRE
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
December 03, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
December 02, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
November 21, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
November 18, 2024
Via ACCESSWIRE
News headline image
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
October 16, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Travelan® continued strong sales growth
October 15, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
October 04, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
September 05, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
August 16, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
August 15, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
August 07, 2024
From Immuron Limited
Via GlobeNewswire
News headline image
Immuron announces record Travelan® sales globally, Australia and USA
July 15, 2024
From Immuron Limited
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap